Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Non-Current Assets: 2018-2021

Historic Non-Current Assets for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $32.6 million.

  • Black Diamond Therapeutics' Non-Current Assets rose 225.57% to $32.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $32.6 million, marking a year-over-year increase of 225.57%. This contributed to the annual value of $10.1 million for FY2020, which is 291.94% up from last year.
  • As of Q3 2021, Black Diamond Therapeutics' Non-Current Assets stood at $32.6 million, which was up 92.38% from $16.9 million recorded in Q2 2021.
  • Black Diamond Therapeutics' Non-Current Assets' 5-year high stood at $141.2 million during Q2 2020, with a 5-year trough of $142,000 in Q4 2018.
  • Its 3-year average for Non-Current Assets is $28.8 million, with a median of $13.0 million in 2020.
  • Data for Black Diamond Therapeutics' Non-Current Assets shows a peak YoY increase of 2,119.25% (in 2021) and a maximum YoY decrease of 88.01% (in 2021) over the last 5 years.
  • Quarterly analysis of 4 years shows Black Diamond Therapeutics' Non-Current Assets stood at $142,000 in 2018, then soared by 1,717.61% to $2.6 million in 2019, then skyrocketed by 291.94% to $10.1 million in 2020, then spiked by 225.57% to $32.6 million in 2021.
  • Its Non-Current Assets stands at $32.6 million for Q3 2021, versus $16.9 million for Q2 2021 and $15.9 million for Q1 2021.